BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Leukocyte
,
Holistic medicine
,
Bleomycin
,
rs4950928
,
MDM2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
proteinases
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Lack of Cathepsin D in the central nervous system results in microglia and astrocyte activation and …
Role of cathepsin D induced by Porphyromonas gingivalis lipopolysaccharide in periodontitis.
Molecular characterization and functional analysis of the lysosomal cathepsin D-like gene in red swa…
Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis an…
Cathepsin D Drives the Formation of Hybrid Insulin Peptides Relevant to the Pathogenesis of Type 1 D…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitali…
Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase …
Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Protei…
Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency
Aralast alpha1-proteinase Inhibitor Surveillance Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ